← 홈

Antibody · VEGF

151개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 151개
AntibodystaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib (Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib)

Platinum-sensitive Relapsed Ovarian Cancer · Platinum-sensitive Relapsed Ovarian Canc

#Platinum-sensitiveRelapsedOvaria#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleLei LiPhase 2

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

Ovarian Carcinoma; Platinum-resistant Ovarian Cancer · Ovarian Carcinoma

#OvarianCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Aribulin;carboplatin;bevacizumab (Aribulin;carboplatin;bevacizumab)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab combined with bevacizumab combined with β- alanine)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab, RHUMAB VEGF (Avastin, Avastin (Bevacizumab, RHUMAB VEGF))

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

bevacizumab, reference product (Avastin®, Avastin® (bevacizumab, reference product))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase1#항체#면역항체+2
효능 ORR 5%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Belinostat, carboplatin, paclitaxel and bevacizumab (Belinostat, carboplatin, paclitaxel and bevacizumab)

Non-Small-Cell Lung Carcinoma · Non-Small-Cell Lung Carcinoma

#Non-Small-CellLungCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleXinqiao Hospital of ChongqingPhase 2

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

NSCLC Stage IV Without EGFR/ALK Mutation · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

ranibizumab (Lucentis, Bevacizumab, Ranibizumab)

Retinopathy of Prematurity Both Eyes · Retinopathy of Prematurity Both Eyes

#RetinopathyofPrematurityBothEyes#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleProgen PharmaceuticalsPhase 1

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Cancer · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJiangsu HengruiPhase 2

Camrelizumab and Bevacizumab (Camrelizumab and Bevacizumab)

Recurrent Glioblastoma · Recurrent Glioblastoma

#RecurrentGlioblastoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSouth Eastern European Research…Phase 2

Capecitabine and Bevacizumab (Capecitabine and Bevacizumab)

Breast Cancer; Metastasis · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 42.9%임상시험 1상태 ACTIVE
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and paclitaxel plus atezolizumab and bevacizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Cryoablation Combined with Tirelizumab and Bevacizumab (Cryoablation Combined with Tirelizumab and Bevacizumab)

Metastatic Breast Cancer in the Liver · Metastatic Breast Cancer in the Liver

#MetastaticBreastCancerintheLiver#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

2 / 8 페이지

← 이전다음 →